Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts Eye and Ear Infirmary
With
Genentech, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with newly diagnosed choroidal melanoma undergoing proton therapy
Tumors \>15 mm in largest diameter and/or \>5 mm in height
Tumors ≤ 15 mm in largest diameter and ≤ 5 mm in height located ≤ 3 mm from optic disc and/or macula, with best-corrected visual acuity 20/100 or better in study eye
You may not be if
History of prior treatment for choroidal melanoma
Pregnancy or lactation
Presence of diabetic retinopathy
History of retinal vascular occlusion or other retinal vascular disease
Active ocular inflammation or history of uveitis in either eye
History of uncontrolled glaucoma (defined as intraocular pressure \>30mmHg despite treatment with anti-glaucoma medication) or filtering surgery in the study eye
Previous intravitreal injections of Avastin® in the study eye or in the non-study eye within 30 days.
Concurrent use of systemic anti-VEGF therapy
Clareo Health | Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
